Literature DB >> 26454376

Polymeric nanostructures with pH-labile core for controlled drug release.

Rakesh Banerjee1, Saikat Maiti1, Debabrata Dey1, Dibakar Dhara2.   

Abstract

Efficient and stimuli-triggered controlled delivery of therapeutics is one of the important issues in modern advanced therapy. In the present work, a versatile route for the synthesis of core cross-linked polymeric nanostructures (CLPN) through thiol-acrylate Michael addition reaction via the formation of β-thiopropionate has been described. The acid groups of the poly(acrylic acid) block of poly(ethylene glycol)-b-poly(N-isopropylacrylamide)-b-poly(acrylic acid) triblock copolymer were reacted with 2-hydroxyethyl acrylate (HEA) to yield the corresponding acrylate-functionalized copolymer (P1). Following this, P1 was reacted with a thiol functionalized cross-linker (CL) resulting in the formation of core cross-linked polymeric nanoparticles through acrylate-thiol Michael reaction. The ability of these nanoparticles to encapsulate drug molecules inside their core and their effective release following a pH-triggered controlled degradation of the core were demonstrated. The temperature sensitive release behaviour of the system was also studied. The non-toxic nature of the precursor polymers and the core cross-linked polymeric nanoparticles was also established, that further substantiated their potential as carriers for controlled release of drugs.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Block copolymers; Polymer colloids; Prednisolone; RAFT polymers; Thermosensitive release; Thiol–acrylate Michael addition; pH-triggered degradation

Mesh:

Substances:

Year:  2015        PMID: 26454376     DOI: 10.1016/j.jcis.2015.09.068

Source DB:  PubMed          Journal:  J Colloid Interface Sci        ISSN: 0021-9797            Impact factor:   8.128


  1 in total

1.  Controlling Indomethacin Release through Vapor-Phase Deposited Hydrogel Films by Adjusting the Cross-linker Density.

Authors:  Paul Christian; Stephan Tumphart; Heike M A Ehmann; Hans Riegler; Anna Maria Coclite; Oliver Werzer
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.